The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci188165
Affiliations:
8
Authors:
18
Institutions Authors Share
University of Copenhagen (UCPH), Denmark
11.000000
11.000000
0.61
Netherlands Cancer Institute (NKI), Netherlands
3.500000
0.19
Copenhagen University Hospital (CUH), Denmark
2.000000
0.11
Oncode Institute, Netherlands
1.500000
0.08